Rosen, a leading law firm, encourages regeneron pharmaceuticals, inc. investors to secure counsel before important deadline in securities class action - regn

New york, ny / access newswire / january 21, 2025 / why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of regeneron pharmaceuticals, inc. (nasdaq:regn) between november 2, 2023 and october 30, 2024, both dates inclusive (the "class period"). a class action lawsuit has already been filed.
REGN Ratings Summary
REGN Quant Ranking